A phase I study of the AKT inhibitor (MK-2206) with concurrent trastuzumab and lapatinib in patients with HER2-positive solid tumors Meeting Abstract

  

Authors:	Han, H. S.; Swanton, C.; Janjigian, Y. Y.; Sutherland, S. C.; Chandarlapaty, S.; Lehman, R.; Hamilton, N.; Knowles, J.; Lee, R.; Yan, L.; Sullivan, D.; Hudis, C.
Abstract Title:	A phase I study of the AKT inhibitor (MK-2206) with concurrent trastuzumab and lapatinib in patients with HER2-positive solid tumors
Meeting Title:	47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	15 Suppl.
Meeting Dates:	2011 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-05-20
Language:	English
ACCESSION:	WOS:000208880301457
DOI:	10.1200/jco.2011.29.15_suppl.3028
PROVIDER:	wos
Notes:	Meeting Abstract: 3028 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141440